MPWT
RAPT

MassMutual Private Wealth & Trust’s RAPT Therapeutics RAPT Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30
Closed -$373 – 2461
2024
Q4 		$373 Buy
+30
New +$381 ﹤0.01% 2188

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

MassMutual Private Wealth & Trust's RAPT Position: Q1 2025 in Review

MassMutual Private Wealth & Trust sold out of RAPT Therapeutics (RAPT) in Q1 2025, closing a stake of 30 shares — an estimated $373 sold.

MassMutual Private Wealth & Trust first reported a position in RAPT in Q4 2024 and held it in 1 quarter. The position peaked at $373 in Q4 2024. 92 funds tracked by Wall St. Rank hold RAPT as of Q1 2025.

  • MassMutual Private Wealth & Trust reported no remaining RAPT Therapeutics position as of Q1 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 30 RAPT Therapeutics shares in Q1 2025, an estimated $373.
  • MassMutual Private Wealth & Trust first reported a position in RAPT Therapeutics in Q4 2024 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's RAPT Therapeutics position peaked at $373 in Q4 2024.
  • 92 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2025, filed 1 Apr 2025.